The Oncology Institute, Inc. (TOI)

NASDAQ: TOI · Real-Time Price · USD

1.480

+0.220 (17.46%)

At close: Apr 2, 2025, 4:00 PM

1.470

-0.010 (-0.68%)

After-hours: Apr 2, 2025, 4:38 PM EDT

The Oncology Institute Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for The Oncology Institute.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for The Oncology Institute.

Recommendation Trends

Rating	Sep '23	Oct '23	Nov '23	Dec '23	Jan '24
Strong Buy	2	2	2	2	2
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jack Slevin Jefferies	Jefferies	Strong Buy Initiates $2.5	Strong Buy	Initiates	$2.5	+68.92%	Feb 26, 2024
Sandy Draper Guggenheim	Guggenheim	Strong Buy Maintains $3 → $2	Strong Buy	Maintains	$3 → $2	+35.14%	Jun 16, 2023
Sandy Draper Guggenheim	Guggenheim	Hold Maintains $6 → $3	Hold	Maintains	$6 → $3	+102.70%	Mar 20, 2023
Sandy Draper Guggenheim	Guggenheim	Strong Buy Maintains $7 → $6	Strong Buy	Maintains	$7 → $6	+305.41%	Nov 11, 2022
Brian Tanquilut Jefferies	Jefferies	Strong Buy Initiates $10	Strong Buy	Initiates	$10	+575.68%	Aug 15, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

487.63M

from 393.41M

23.95%

from 393.41M

Revenue Next Year

n/a

from 487.63M

EPS This Year

-0.16

from -0.71

EPS Next Year

n/a

from -0.16

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	187.52M	203.00M	252.48M	324.24M	393.41M	487.63M
Revenue Growth	20.66%	8.26%	24.37%	28.42%	21.33%	23.95%
EPS	-0.24	-0.16	-0.21	-0.92	-0.71	-0.16
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025
High	506.9M
Avg	487.6M
Low	473.1M

Revenue Growth

Revenue Growth	2025
High	28.9%
Avg	23.9%
Low	20.3%

EPS Forecast

EPS	2025
High	-0.17
Avg	-0.16
Low	-0.16

EPS Growth

EPS Growth	2025
High	-
Avg	-
Low	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.